Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,300 papers from all fields of science
Search
Sign In
Create Free Account
hydroxyprogesterone caproate (USP)
Known as:
caproate hydroxyprogesterone
, 17-alpha-hydroxy-progesterone caproate
, Hydroxyprogesterone Caproate
Expand
A synthetic progestational agent similar to the endogenous progesterone used in hormone therapy or as a female contraceptive. Mimicking the action of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
1 ML hydroxyprogesterone caproate (USP) 250 MG/ML Injection [Makena]
Amenorrhea
Drug Allergy
Endometriosis
Expand
Broader (4)
17-alpha-Hydroxyprogesterone
Estrogen Antagonists
Hydroxyprogesterones
Progestins
Narrower (4)
Delalutin
Makena
Neolutin
Prolutin Depot
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
K. Heyborne
,
A. Allshouse
,
J. Carey
American Journal of Obstetrics and Gynecology
2015
Corpus ID: 25945661
Review
2009
Review
2009
Comparing diagnostic methods for mental disorders in China
Lawrence H. Yang
,
Bruce G. Link
The Lancet
2009
Corpus ID: 9144619
2008
2008
17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
F. Facchinetti
,
G. Dante
,
P. Venturini
,
S. Paganelli
,
A. Volpe
American Journal of Perinatology
2008
Corpus ID: 206284681
We evaluated if the inhibitory effect of 17alpha-hydroxyprogesterone caproate (17P) on cervical ripening is mediated by cervical…
Expand
2007
2007
Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
H. How
,
J. Barton
,
N. Istwan
,
D. Rhea
,
G. Stanziano
American Journal of Obstetrics and Gynecology
2007
Corpus ID: 11398485
2005
2005
Polyunsaturated fatty acids and risk of preterm delivery.
F. Facchinetti
,
M. Fazzio
,
P. Venturini
European Review for Medical and Pharmacological…
2005
Corpus ID: 43395730
Preterm delivery (PD) is characterized both by increased neonatal morbidity and mortality and by important late pathologic…
Expand
1993
1993
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the…
J. Carbone
,
R. Brent
American Journal of Obstetrics and Gynecology
1993
Corpus ID: 36749498
1982
1982
Evaluation of the use of prolution‐depot (hydroxyprogesterone hexanoate) in early pregnancy
T. Varma
,
J. Morsman
International journal of gynaecology and…
1982
Corpus ID: 23107681
1979
1979
High‐Risk Prematurity—Progestin Treatment and Steroid Studies
John W. C. Johnson
,
P. A. Lee
,
Annelies S. Zachary
,
Shirley Calhoun
,
C. Migeon
Obstetrics and Gynecology
1979
Corpus ID: 37389123
Studies have been undertaken regarding the efficacy and modus operandi of 17α-hydroxyprogesterone caproate (17α-OHP-C) in…
Expand
Highly Cited
1971
Highly Cited
1971
Hydroxyprogesterone caproate therapy in advanced endometrial cancer
E. C. Reifenstein
Cancer
1971
Corpus ID: 37473914
In 314 women with advanced progressing adenocarcinoma of the uterine corpus (endometrial cancer) no longer responding to…
Expand
1961
1961
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
A. Varga
,
E. Henriksen
Obstetrics and Gynecology
1961
Corpus ID: 72906611
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE